GLYPHOSATE VEDOTIN FOR TREATMENT OF BONE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

$112,875FY2014Department of DefenseDOD

The Administrators Of Tulane Educational Fund

Investigators